While the approval of the first DTC pharmacogenomics test provides exciting opportunities to educate the general public about the clinical value of pharmacogenomics, it also must be viewed with caution.
Is It Time to Use Pharmacogenomics to Guide Tamoxifen Dosing?
Is it time for us to use pharmacogenomics to find safe and effective doses of tamoxifen for patients — optimizing clinical outcomes with minimal side effects? Dr. Jennifer Hockings discusses.
The Pharmacogenomics of ADHD Treatment
Pharmacogenomic testing may one day be feasible for ADHD. Jennifer Hockings, PharmD, PhD, explains a growing body of research to-date and what additional work is still needed to make it become a reality.
Genetics and Pain: Optimizing Gene Expression and the Potential of Pharmacogenetics
Knowing how patients metabolize medication could be a powerful tool for doctors seeking the right pain remedies for patients. Pharmacogenomics is a growing industry and one that needs further research to be useful says a Cleveland Clinic pain specialist.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy